AME

Business profile & competitive position

AMETEK, Inc. is classified in the Industrials sector, specifically the Electrical Equipment & Parts industry. Through two operating groups—Electronic Instruments (EIG) and Electromechanical (EMG)—it makes highly specialized components and instruments for process, aerospace, power, industrial, medical, automation and defense end markets. EIG designs advanced analytical, test and measurement instruments, while EMG supplies precision motion-control solutions, engineered medical components, thermal management systems, specialty metals and electrical interconnects.

The financial profile supports the idea that this is a high-quality, niche industrial business. The company’s net margin is 20.0%, and its return on equity is 14.5%. A 20% net margin is well above the typical industrial average, and a mid-teens ROE suggests the company converts capital into shareholder returns at a reasonably efficient rate. For context, AMETEK’s 2025 annual sales were $7,401.1 million, up 6.6% from 2024, with diluted EPS of $6.40, up 7.9%. It also posted record operating income, net income, orders and backlog in 2025. EIG derived 52% of its net sales from outside the U.S., while EMG derived 42% from outside the U.S., and the company employed about 22,500 people at year end. That geographic mix and margin structure are consistent with a diversified supplier of mission-critical parts and instruments rather than a commoditized electrical-components manufacturer.

Financial posture

AMETEK currently carries a market capitalization of $54.5 billion and trades at a P/E ratio of 34.6, with the stock at $237.72. At that valuation, the market is pricing in above-average growth and quality relative to typical industrial peers. The combination of a 20.0% net margin and 14.5% ROE justifies part of that premium, but a 34.6x multiple also leaves little valuation cushion if execution slips.

The stock’s beta of 0.99 means its expected market sensitivity is almost exactly in line with the broad equity market—neither a defensive low-beta name nor a high-beta cyclical. Technically, the current price sits just below the 50-day EMA of $240.27, with an RSI of 45.1, which is neutral territory. In short, AME looks like a high-multiple industrial compounder whose valuation assumes continued margin discipline and mid-to-high single-digit top-line growth.

Strategic priorities & outlook

AMETEK’s most recent 10-K lays out four interconnected strategic priorities. The first is execution of the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash generation and a superior return on total capital. The second is Operational Excellence, pursued through lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, and increasingly through digitalization and artificial intelligence.

The third priority is acquisitions. From 2021 through Dec. 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone it spent $933.2 million in cash, net of cash acquired, to buy Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). The stated acquisition criteria emphasize strategic, technical and cultural fit in adjacent or complementary markets aligned with secular growth themes. Finally, the company is expanding globally with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia, designed to support customer proximity and international growth.

Macro & geopolitical exposure

Because AMETEK sits in the Electrical Equipment & Parts industry, its exposures are largely macro-industrial rather than consumer-driven. Key external factors include raw-material and component costs—copper, specialty metals, semiconductors and rare-earth materials used in precision instruments and interconnects—along with global supply-chain resilience. Currency translation is a measurable factor given that 52% of EIG sales and 42% of EMG sales go to customers outside the United States.

The business is also tied to capital-spending cycles in aerospace, defense, power, medical devices and automation, plus any shifts in industrial policy such as tariffs, friend-shoring incentives or export controls. Regulation around aerospace and medical-device components is another industry-wide consideration. The beta of 0.99 suggests these macro sensitivities aggregate to roughly market-level volatility rather than extreme cyclicality.

Recent developments

Several recent news items frame the current narrative. On Aug. 26, 2026, AMETEK completed the acquisition of Indicor Instrumentation, according to PR Newswire, continuing the M&A-driven strategy described in its 10-K. On Sept. 1, 2026, Seeking Alpha published a bullish thematic note titled “Ametek: The Quiet Control Layer Behind The Next Industrial Investment Cycle,” highlighting the company’s role as an enabler of automation and process control.

However, sentiment has not been uniformly positive. On Sept. 3, 2026, Zacks asked “Why Is Ametek (AME) Down 8.5% Since Last Earnings Report?,” underscoring that a post-earnings beat has not prevented a broader pullback. The stock’s price of $237.72 is indeed well off recent highs, and the 8.5% pullback is noteworthy even though the Aug. 4, 2026 report beat the market’s real expectation by 5% with actual EPS of $2.09 versus an estimate of $1.99. On Sept. 4, 2026, Seeking Alpha also reported that AMETEK appeared in Baron’s SMID Cap ETF Q2 2026 portfolio activity.

Earnings behavior & post-earnings drift

AMETEK has delivered a perfect beat rate recently: 8 for 8 over the last eight reported quarters, with an average earnings surprise of 4%. Despite that consistency, the post-earning price drift has been minimal. The average 5-day move after earnings across those eight quarters is just 0.46%, classified as “flat.” That pattern means beats have largely been priced in or offset by forward-looking commentary.

The last four reports illustrate how uneven the reaction can be despite the beats. On Aug. 4, 2026, AMETEK reported $2.09 versus an estimate of $1.99—a 5.0% surprise—and the stock rose 0.28% the next day and 0.89% over the following five days. On April 30, 2026, EPS of $1.97 beat the $1.90 estimate by 3.7%, yet the stock fell 2.13% the next day and 0.33% over five days. The Feb. 3, 2026 quarter delivered $2.01 versus $1.94, a 3.6% surprise, with the stock down 0.48% the next day but up 1.83% over the next five sessions. On Oct. 30, 2025, the company beat by 7.4% ($1.89 vs. $1.76), gaining 1.91% the next day before drifting 0.54% lower over five days.

The next scheduled report is Oct. 29, 2026 before the open, with a consensus EPS estimate of $2.11. That estimate implies modest sequential growth from the $2.09 reported in the previous quarter and represents the unofficial consensus of analysts heading into the print.

For a deeper dive into valuation models, analyst revisions and the complete institutional view on AMETEK, review the full institutional verdict available on the platform.